ARWR
NASDAQ
$74.52
Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $96 (+28.82%)
Market Cap
$10B
Revenue 5Y CAGR
+47.49%
Free Cash Flow Yield
-0.50%
Beta (5Y)
1.63
Price Chart
Valuation
Market Cap$10B
Forward P/E111.11
P/S16.28
P/B17.01
Profitability
Total Revenue (TTM)$622M
Gross Profit (TTM)$622M
EBITDA-$198M
Profit Margin-48.4%
Operating Margin-191.6%
EPS-$2.16
Financial Health
Free Cash Flow Yield-0.50%
Growth & Risk
EPS 5Y CAGR+15.23%
Revenue 5Y CAGR+47.49%
Beta (5Y)1.63
Sharpe Ratio2.31